Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 82

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Gαs–Protein Kinase A (PKA) Pathway Signalopathies: The Emerging Genetic Landscape and Therapeutic Potential of Human Diseases Driven by Aberrant Gαs-PKA Signaling

Ramms, Dana J., Raimondi, Francesco, Arang, Nadia, Herberg, Friedrich W., Taylor, Susan S., Gutkind, J. Silvio · 2021 · Pharmacological Reviews

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1124/pharmrev.120.000269

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Research works printed but not linked: 392

  1. Acin-Perez, 2009, Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation, Cell Metab, 9, 265, 10.1016/j.cmet.2009.01.012 · DOI · Paper page
  2. Adams, 1995, Phosphorylation modulates catalytic function and regulation in the cAMP-dependent protein kinase, Biochemistry, 34, 2447, 10.1021/bi00008a007 · DOI
  3. Alakus, 2014, Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin, Genome Med, 6, 43, 10.1186/gm559 · DOI
  4. Alberini, 1994, C/EBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia, Cell, 76, 1099, 10.1016/0092-8674(94)90386-7 · DOI · Paper page
  5. Ali, 2015, Updated global burden of cholera in endemic countries, PLoS Negl Trop Dis, 9, 10.1371/journal.pntd.0003832 · DOI · Paper page
  6. Almeida, 2012, Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations, J Clin Endocrinol Metab, 97, E687, 10.1210/jc.2011-3000 · DOI
  7. Almeida, 2010, Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/- or Rb1+/- backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signaling, Hum Mol Genet, 19, 1387, 10.1093/hmg/ddq014 · DOI
  8. Altarejos, 2011, CREB and the CRTC co-activators: sensors for hormonal and metabolic signals, Nat Rev Mol Cell Biol, 12, 141, 10.1038/nrm3072 · DOI · Paper page
  9. Amarante, 2018, Potential use of CXCL12/CXCR4 and sonic hedgehog pathways as therapeutic targets in medulloblastoma, Acta Oncol, 57, 1134, 10.1080/0284186X.2018.1473635 · DOI
  10. Amato, 2014, Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas, J Pathol, 233, 217, 10.1002/path.4344 · DOI · Paper page
  11. Amieux, 2002, The essential role of RI alpha in the maintenance of regulated PKA activity, Ann N Y Acad Sci, 968, 75, 10.1111/j.1749-6632.2002.tb04328.x · DOI · Paper page
  12. Ang, 2018, Genomic landscape of appendiceal neoplasms, JCO Precis Oncol, 2, 1, 10.1200/PO.17.00302 · DOI
  13. Angers, 2009, Proximal events in Wnt signal transduction, Nat Rev Mol Cell Biol, 10, 468, 10.1038/nrm2717 · DOI · Paper page
  14. Arang, 2020, G protein-coupled receptors and heterotrimeric G proteins as cancer drivers, FEBS Lett, 594, 4201, 10.1002/1873-3468.14017 · DOI
  15. Arveseth, 2021, Smoothened transduces Hedgehog signals via activity-dependent sequestration of PKA catalytic subunits, PLoS Biol, 19, 10.1371/journal.pbio.3001191 · DOI
  16. Asare, 2016, The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base, Cancer, 122, 213, 10.1002/cncr.29744 · DOI · Paper page
  17. Ashworth, 2018, Synthetic lethal therapies for cancer: what’s next after PARP inhibitors?, Nat Rev Clin Oncol, 15, 564, 10.1038/s41571-018-0055-6 · DOI · Paper page
  18. Bachmann, 2016, Gpr161 anchoring of PKA consolidates GPCR and cAMP signaling, Proc Natl Acad Sci USA, 113, 7786, 10.1073/pnas.1608061113 · DOI · Paper page
  19. Bacskai, 1993, Spatially resolved dynamics of cAMP and protein kinase A subunits in Aplysia sensory neurons, Science, 260, 222, 10.1126/science.7682336 · DOI · Paper page
  20. Barzi, 2010, Sonic-hedgehog-mediated proliferation requires the localization of PKA to the cilium base, J Cell Sci, 123, 62, 10.1242/jcs.060020 · DOI
  21. Bates, 2006, Characterization of Gpr101 expression and G-protein coupling selectivity, Brain Res, 1087, 1, 10.1016/j.brainres.2006.02.123 · DOI
  22. Bathon, 2019, Alterations in protein kinase a substrate specificity as a potential cause of cushing syndrome, Endocrinology, 160, 447, 10.1210/en.2018-00775 · DOI · Paper page
  23. Bender, 2006, Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use, Pharmacol Rev, 58, 488, 10.1124/pr.58.3.5 · DOI · Paper page
  24. Bendzunas, 2018, Investigating PKA-RII specificity using analogs of the PKA:AKAP peptide inhibitor STAD-2, Bioorg Med Chem, 26, 1174, 10.1016/j.bmc.2018.02.001 · doi:10.1016/j.bmc.2018.02.001
  25. Bentin Toaldo, 2015, Protein kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13, BMC Cancer, 15, 588, 10.1186/s12885-015-1591-4 · doi:10.1186/s12885-015-1591-4
  26. Berman, 2005, The cAMP binding domain: an ancient signaling module, Proc Natl Acad Sci USA, 102, 45, 10.1073/pnas.0408579102 · DOI · Paper page
  27. Bertherat, 2009, Mutations in regulatory subunit type 1A of cyclic adenosine 5′-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes, J Clin Endocrinol Metab, 94, 2085, 10.1210/jc.2008-2333 · DOI · Paper page
  28. Bertinetti, 2009, Chemical tools selectively target components of the PKA system, BMC Chem Biol, 9, 3, 10.1186/1472-6769-9-3 · DOI
  29. Beuschlein, 2014, Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome, N Engl J Med, 370, 1019, 10.1056/NEJMoa1310359 · DOI · Paper page
  30. Bharati, 2011, Cholera toxin: a paradigm of a multifunctional protein, Indian J Med Res, 133, 179
  31. Bi, 2017, Clinical identification of oncogenic drivers and copy-number alterations in pituitary tumors, Endocrinology, 158, 2284, 10.1210/en.2016-1967 · DOI
  32. Bian, 2007, Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival, Neurosurgery, 61, 570, 10.1227/01.NEU.0000290905.53685.A2 · DOI
  33. Bianco, 1998, Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells, J Clin Invest, 101, 1737, 10.1172/JCI2361 · DOI · Paper page
  34. Biel, 2009, Cyclic nucleotide-regulated cation channels, J Biol Chem, 284, 9017, 10.1074/jbc.R800075200 · doi:10.1074/jbc.r800075200
  35. Bitterman, 2013, Pharmacological distinction between soluble and transmembrane adenylyl cyclases, J Pharmacol Exp Ther, 347, 589, 10.1124/jpet.113.208496 · DOI
  36. Blair, 2019, Reshaping cAMP nanodomains through targeted disruption of compartmentalised phosphodiesterase signalosomes, Biochem Soc Trans, 47, 1405, 10.1042/BST20190252 · DOI
  37. Bock, 2020, Optical mapping of cAMP signaling at the nanometer scale, Cell, 182, 1519, 10.1016/j.cell.2020.07.035 · DOI · Paper page
  38. Boikos, 2007, Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis, Hum Mol Genet, 16, R80, 10.1093/hmg/ddm019 · DOI
  39. Boora, 2015, Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines, Cancer Genet, 208, 374, 10.1016/j.cancergen.2015.04.002 · DOI
  40. Boswell-Smith, 2006, Phosphodiesterase inhibitors, Br J Pharmacol, 147, S252
  41. Bradley, 2005, Regulation of cyclic nucleotide-gated channels, Curr Opin Neurobiol, 15, 343, 10.1016/j.conb.2005.05.014 · DOI
  42. Bramson, 1984, Mechanistic studies of cAMP-dependent protein kinase action, CRC Crit Rev Biochem, 15, 93, 10.3109/10409238409102298 · DOI
  43. Brasaemle, 2009, Perilipin A and the control of triacylglycerol metabolism, Mol Cell Biochem, 326, 15, 10.1007/s11010-008-9998-8 · DOI · Paper page
  44. Brockmann, 2017, Genetic wiring maps of single-cell protein states reveal an off-switch for GPCR signalling, Nature, 546, 307, 10.1038/nature22376 · DOI · Paper page
  45. Brogna, 2009, Nonsense-mediated mRNA decay (NMD) mechanisms, Nat Struct Mol Biol, 16, 107, 10.1038/nsmb.1550 · DOI · Paper page
  46. Brown, 2005, COX-2: a molecular target for colorectal cancer prevention, J Clin Oncol, 23, 2840, 10.1200/JCO.2005.09.051 · DOI · Paper page
  47. Brown, 2006, The pharmacology of cyclic nucleotide-gated channels: emerging from the darkness, Curr Pharm Des, 12, 3597, 10.2174/138161206778522100 · DOI
  48. Brown, 2013, Implementing fluorescence anisotropy screening and crystallographic analysis to define PKA isoform-selective activation by cAMP analogs, ACS Chem Biol, 8, 2164, 10.1021/cb400247t · DOI
  49. Brunelli, 1976, Synaptic facilitation and behavioral sensitization in Aplysia: possible role of serotonin and cyclic AMP, Science, 194, 1178, 10.1126/science.186870 · DOI · Paper page
  50. Bruystens, 2016, Structure of a PKA RIα recurrent acrodysostosis mutant explains defective cAMP-dependent activation, J Mol Biol, 428, 4890, 10.1016/j.jmb.2016.10.033 · DOI · Paper page
  51. Buckman, 1998, COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer, Carcinogenesis, 19, 723, 10.1093/carcin/19.5.723 · DOI · Paper page
  52. Bucko, 2020, Drugs that regulate local cell signaling: AKAP targeting as a therapeutic option, Annu Rev Pharmacol Toxicol, 61, 361, 10.1146/annurev-pharmtox-022420-112134 · DOI
  53. Bucko, 2019, Subcellular drug targeting illuminates local kinase action, eLife, 8, 10.7554/eLife.52220 · DOI
  54. Calatozzolo, 2006, Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas, Cancer Biol Ther, 5, 827, 10.4161/cbt.5.7.2838 · doi:10.4161/cbt.5.7.2838
  55. Calebiro, 2014, PKA catalytic subunit mutations in adrenocortical Cushing’s adenoma impair association with the regulatory subunit, Nat Commun, 5, 5680, 10.1038/ncomms6680 · DOI · Paper page
  56. Calejo, 2015, Targeting protein-protein interactions in complexes organized by A kinase anchoring proteins, Front Pharmacol, 6, 192, 10.3389/fphar.2015.00192 · DOI
  57. Campbell, 2018, Targeting G protein-coupled receptor signalling by blocking G proteins, Nat Rev Drug Discov, 17, 789, 10.1038/nrd.2018.135 · DOI · Paper page
  58. Cannaerts, 2015, TGF-β signalopathies as a paradigm for translational medicine, Eur J Med Genet, 58, 695, 10.1016/j.ejmg.2015.10.010 · DOI
  59. Cao, 2019, Structures of the PKA RIα holoenzyme with the FLHCC driver J-PKAcα or wild-type PKAcα, Structure, 27, 816, 10.1016/j.str.2019.03.001 · doi:10.1016/j.str.2019.03.001
  60. Carballo, 2018, A highlight on Sonic hedgehog pathway, Cell Commun Signal, 16, 11, 10.1186/s12964-018-0220-7 · DOI · Paper page
  61. Carney, 1985, Differences between nonfamilial and familial cardiac myxoma, Am J Surg Pathol, 9, 53, 10.1097/00000478-198501000-00009 · doi:10.1097/00000478-198501000-00009
  62. Carr, 1992, Localization of the cAMP-dependent protein kinase to the postsynaptic densities by A-kinase anchoring proteins. Characterization of AKAP 79, J Biol Chem, 267, 16816, 10.1016/S0021-9258(18)41856-X · DOI · Paper page
  63. Castellone, 2005, Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis, Science, 310, 1504, 10.1126/science.1116221 · DOI · Paper page
  64. Castellucci, 1980, Intracellular injection of the catalytic subunit of cyclic AMP-dependent protein kinase simulates facilitation of transmitter release underlying behavioral sensitization in Aplysia, Proc Natl Acad Sci USA, 77, 7492, 10.1073/pnas.77.12.7492 · DOI · Paper page
  65. Chan, 2005, Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer, JAMA, 294, 914, 10.1001/jama.294.8.914 · DOI · Paper page
  66. Chang, 2007, Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology, J Biol Chem, 282, 21583, 10.1074/jbc.C700083200 · DOI · Paper page
  67. Chen, 2007, Mutation of an A-kinase-anchoring protein causes long-QT syndrome, Proc Natl Acad Sci USA, 104, 20990, 10.1073/pnas.0710527105 · DOI · Paper page
  68. Cheng, 1985, An active twenty-amino-acid-residue peptide derived from the inhibitor protein of the cyclic AMP-dependent protein kinase, Biochem J, 231, 655, 10.1042/bj2310655 · DOI
  69. Chepurny, 2013, Stimulation of proglucagon gene expression by human GPR119 in enteroendocrine L-cell line GLUTag, Mol Endocrinol, 27, 1267, 10.1210/me.2013-1029 · DOI
  70. Cheung, 2015, Structural insights into mis-regulation of protein kinase A in human tumors, Proc Natl Acad Sci USA, 112, 1374, 10.1073/pnas.1424206112 · DOI · Paper page
  71. Chijiwa, 1990, J Biol Chem, 265, 5267, 10.1016/S0021-9258(19)34116-X · DOI · Paper page
  72. Chin, 2017, Current insights into the role of PKA phosphorylation in CFTR channel activity and the pharmacological rescue of cystic fibrosis disease-causing mutants, Cell Mol Life Sci, 74, 57, 10.1007/s00018-016-2388-6 · DOI
  73. Christensen, 2003, cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension, J Biol Chem, 278, 35394, 10.1074/jbc.M302179200 · DOI · Paper page
  74. Colao, 2014, Managing hyperglycemia in patients with Cushing's disease treated with pasireotide: medical expert recommendations, Pituitary, 17, 180, 10.1007/s11102-013-0483-3 · DOI
  75. Coles, 2020, Unbiased proteomic profiling uncovers a targetable GNAS/PKA/PP2A axis in small cell lung cancer stem cells, Cancer Cell, 38, 129, 10.1016/j.ccell.2020.05.003 · DOI
  76. Cook, 1993, Inhibition by cAMP of Ras-dependent activation of Raf, Science, 262, 1069, 10.1126/science.7694367 · DOI · Paper page
  77. Cornella, 2015, Unique genomic profile of fibrolamellar hepatocellular carcinoma, Gastroenterology, 148, 806, 10.1053/j.gastro.2014.12.028 · DOI
  78. Correa, 2015, Carney complex: an update, Eur J Endocrinol, 173, M85, 10.1530/EJE-15-0209 · DOI · Paper page
  79. Dagda, 2015, Role of protein kinase A in regulating mitochondrial function and neuronal development: implications to neurodegenerative diseases, Rev Neurosci, 26, 359, 10.1515/revneuro-2014-0085 · DOI
  80. Dash, 1990, Injection of the cAMP-responsive element into the nucleus of Aplysia sensory neurons blocks long-term facilitation, Nature, 345, 718, 10.1038/345718a0 · DOI · Paper page
  81. De Leo, 2016, Hyperthyroidism, Lancet, 388, 906, 10.1016/S0140-6736(16)00278-6 · DOI · Paper page
  82. De Venanzi, 2014, Primary bilateral macronodular adrenal hyperplasia, Curr Opin Endocrinol Diabetes Obes, 21, 177, 10.1097/MED.0000000000000061 · DOI · Paper page
  83. Deeble, 2007, Androgen-independent growth and tumorigenesis of prostate cancer cells are enhanced by the presence of PKA-differentiated neuroendocrine cells, Cancer Res, 67, 3663, 10.1158/0008-5472.CAN-06-2616 · DOI
  84. Dema, 2016, The A-kinase anchoring protein (AKAP) glycogen synthase kinase 3β interaction protein (GSKIP) regulates β-catenin through its interactions with both protein kinase A (PKA) and GSK3β, J Biol Chem, 291, 19618, 10.1074/jbc.M116.738047 · DOI
  85. DeNinno, 2012, Future directions in phosphodiesterase drug discovery, Bioorg Med Chem Lett, 22, 6794, 10.1016/j.bmcl.2012.09.028 · DOI
  86. Dhillon, 2002, Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259, Mol Cell Biol, 22, 3237, 10.1128/MCB.22.10.3237-3246.2002 · DOI · Paper page
  87. Di Benedetto, 2018, Shaping mitochondrial dynamics: the role of cAMP signalling, Biochem Biophys Res Commun, 500, 65, 10.1016/j.bbrc.2017.05.041 · DOI
  88. Di Vito, 2015, The mysterious pathways of cardiac myxomas: a review of histogenesis, pathogenesis and pathology, Histopathology, 66, 321, 10.1111/his.12531 · DOI
  89. Dilly, 2017, Targeting G-protein coupled receptor-related signaling pathway in a murine xenograft model of appendiceal pseudomyxoma peritonei, Oncotarget, 8, 106888, 10.18632/oncotarget.22455 · DOI
  90. Drew, 2016, Aspirin and colorectal cancer: the promise of precision chemoprevention, Nat Rev Cancer, 16, 173, 10.1038/nrc.2016.4 · DOI · Paper page
  91. Dumaz, 2006, In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling, Cancer Res, 66, 9483, 10.1158/0008-5472.CAN-05-4227 · DOI · Paper page
  92. Durick, 1996, Mitogenic signaling by Ret/ptc2 requires association with enigma via a LIM domain, J Biol Chem, 271, 12691, 10.1074/jbc.271.22.12691 · doi:10.1074/jbc.271.22.12691
  93. Durick, 1995, Tyrosines outside the kinase core and dimerization are required for the mitogenic activity of RET/ptc2, J Biol Chem, 270, 24642, 10.1074/jbc.270.42.24642 · DOI
  94. Dyson, 2009, The differential regulation of steroidogenic acute regulatory protein-mediated steroidogenesis by type I and type II PKA in MA-10 cells, Mol Cell Endocrinol, 300, 94, 10.1016/j.mce.2008.11.029 · DOI
  95. Eichholtz, 1993, A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor, J Biol Chem, 268, 1982, 10.1016/S0021-9258(18)53951-X · DOI
  96. Engh, 1996, Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity, J Biol Chem, 271, 26157, 10.1074/jbc.271.42.26157 · DOI · Paper page
  97. Enkvist, 2006, Conjugation of adenosine and hexa-(D-arginine) leads to a nanomolar bisubstrate-analog inhibitor of basophilic protein kinases, J Med Chem, 49, 7150, 10.1021/jm0605942 · doi:10.1021/jm0605942
  98. Enkvist, 2007, Carbocyclic 3′-deoxyadenosine-based highly potent bisubstrate-analog inhibitor of basophilic protein kinases, Bioorg Med Chem Lett, 17, 5336, 10.1016/j.bmcl.2007.08.016 · doi:10.1016/j.bmcl.2007.08.016
  99. Erion, 2009, Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein, Cell Metab, 10, 499, 10.1016/j.cmet.2009.10.007 · DOI
  100. Espiard, 2018, Activating PRKACB somatic mutation in cortisol-producing adenomas, JCI Insight, 3, 10.1172/jci.insight.98296 · DOI
  101. Fang, 2000, Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A, Proc Natl Acad Sci USA, 97, 11960, 10.1073/pnas.220413597 · DOI · Paper page
  102. Farquhar, 2008, Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity, J Virol, 82, 8797, 10.1128/JVI.00592-08 · DOI
  103. Fearon, 1990, A genetic model for colorectal tumorigenesis, Cell, 61, 759, 10.1016/0092-8674(90)90186-I · DOI · Paper page
  104. Feller, 2009, The nature of fibrous dysplasia, Head Face Med, 5, 22, 10.1186/1746-160X-5-22 · doi:10.1186/1746-160x-5-22
  105. Forlino, 2014, PRKACB and Carney complex, N Engl J Med, 370, 1065, 10.1056/NEJMc1309730 · DOI
  106. Fragoso, 2003, Cushing’s syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene, J Clin Endocrinol Metab, 88, 2147, 10.1210/jc.2002-021362 · DOI · Paper page
  107. Freda, 2002, Somatostatin analogs in acromegaly, J Clin Endocrinol Metab, 87, 3013, 10.1210/jcem.87.7.8665 · doi:10.1210/jcem.87.7.8665 · Paper page
  108. Freda, 2007, Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission, Pituitary, 10, 275, 10.1007/s11102-007-0058-2 · doi:10.1007/s11102-007-0058-2
  109. Gadelha, 2017, The genetic background of acromegaly, Pituitary, 20, 10, 10.1007/s11102-017-0789-7 · DOI
  110. Gao, 2020, PROTAC technology: opportunities and challenges, ACS Med Chem Lett, 11, 237, 10.1021/acsmedchemlett.9b00597 · DOI · Paper page
  111. Giardiello, 1993, Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis, N Engl J Med, 328, 1313, 10.1056/NEJM199305063281805 · DOI · Paper page
  112. Gjertsen, 1995, Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action, J Biol Chem, 270, 20599, 10.1074/jbc.270.35.20599 · DOI · Paper page
  113. Gloerich, 2010, Epac: defining a new mechanism for cAMP action, Annu Rev Pharmacol Toxicol, 50, 355, 10.1146/annurev.pharmtox.010909.105714 · DOI · Paper page
  114. Goel, 2006, A phase I safety and dose escalation trial of docetaxel combined with GEM231, a second generation antisense oligonucleotide targeting protein kinase A R1alpha in patients with advanced solid cancers, Invest New Drugs, 24, 125, 10.1007/s10637-006-2378-x · DOI
  115. Goessling, 2009, Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration, Cell, 136, 1136, 10.1016/j.cell.2009.01.015 · DOI · Paper page
  116. Goh, 2014, Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors [published correction appears in Nat Genet (2014) 46:759], Nat Genet, 46, 613, 10.1038/ng.2956 · DOI · Paper page
  117. Gold, 2013, Engineering A-kinase anchoring protein (AKAP)-selective regulatory subunits of protein kinase A (PKA) through structure-based phage selection, J Biol Chem, 288, 17111, 10.1074/jbc.M112.447326 · DOI
  118. Graham, 2018, Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion, Hepatology, 68, 1441, 10.1002/hep.29719 · DOI
  119. Greene, 2008, In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay, Hum Mutat, 29, 633, 10.1002/humu.20688 · DOI
  120. Greenwald, 2011, Bigger, better, faster: principles and models of AKAP anchoring protein signaling, J Cardiovasc Pharmacol, 58, 462, 10.1097/FJC.0b013e31822001e3 · DOI
  121. Greggio, 2017, Cross-talk between LRRK2 and PKA: implication for Parkinson’s disease?, Biochem Soc Trans, 45, 261, 10.1042/BST20160396 · DOI
  122. Gu, 2009, Protein kinase A activation confers resistance to trastuzumab in human breast cancer cell lines, Clin Cancer Res, 15, 7196, 10.1158/1078-0432.CCR-09-0585 · DOI
  123. Hage, 2018, Genomic Alterations and Complex Subclonal Architecture in Sporadic GH-Secreting Pituitary Adenomas, J Clin Endocrinol Metab, 103, 1929, 10.1210/jc.2017-02287 · DOI
  124. Halls, 2017, Adenylyl cyclase signalling complexes - Pharmacological challenges and opportunities, Pharmacol Ther, 172, 171, 10.1016/j.pharmthera.2017.01.001 · DOI
  125. Ham, 1997, GH3 cells expressing constitutively active Gs alpha (Q227L) show enhanced hormone secretion and proliferation, Mol Cell Endocrinol, 127, 41, 10.1016/S0303-7207(96)03987-1 · doi:10.1016/s0303-7207(96)03987-1
  126. Hamada, 2017, Aspirin use and colorectal cancer survival according to tumor CD274 (programmed cell death 1 ligand 1) expression status, J Clin Oncol, 35, 1836, 10.1200/JCO.2016.70.7547 · DOI
  127. Hammarsjö, 2021, High diagnostic yield in skeletal ciliopathies using massively parallel genome sequencing, structural variant screening and RNA analyses, J Hum Genet, 10.1038/s10038-021-00925-x · DOI
  128. Hamuro, 2004, Mapping intersubunit interactions of the regulatory subunit (RIalpha) in the type I holoenzyme of protein kinase A by amide hydrogen/deuterium exchange mass spectrometry (DXMS), J Mol Biol, 340, 1185, 10.1016/j.jmb.2004.05.042 · DOI
  129. Hanke, 2011, Cyclic nucleotides as affinity tools: phosphorothioate cAMP analogues address specific PKA subproteomes, N Biotechnol, 28, 294, 10.1016/j.nbt.2010.12.001 · doi:10.1016/j.nbt.2010.12.001
  130. Hanks, 1995, Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification, FASEB J, 9, 576, 10.1096/fasebj.9.8.7768349 · DOI · Paper page
  131. Hannah-Shmouni, 2016, Genetics of gigantism and acromegaly, Growth Horm IGF Res, 30-31, 37, 10.1016/j.ghir.2016.08.002 · doi:10.1016/j.ghir.2016.08.002
  132. Hanoune, 2001, Regulation and role of adenylyl cyclase isoforms, Annu Rev Pharmacol Toxicol, 41, 145, 10.1146/annurev.pharmtox.41.1.145 · DOI · Paper page
  133. Hansen-Petrik, 2002, Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice, Cancer Res, 62, 403
  134. Hata, 2004, Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation, Pharmacol Ther, 103, 147, 10.1016/j.pharmthera.2004.06.003 · DOI · Paper page
  135. He, 2017, Recurrent somatic mutations of PRKAR1A in isolated cardiac myxoma, Oncotarget, 8, 103968, 10.18632/oncotarget.21916 · DOI
  136. He, 2014, The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog-driven medulloblastoma, Nat Med, 20, 1035, 10.1038/nm.3666 · DOI
  137. Hébrant, 2011, Genetic hyperthyroidism: hyperthyroidism due to activating TSHR mutations, Eur J Endocrinol, 164, 1, 10.1530/EJE-10-0775 · DOI
  138. Herberg, 1993, Physiological inhibitors of the catalytic subunit of cAMP-dependent protein kinase: effect of MgATP on protein-protein interactions, Biochemistry, 32, 14015, 10.1021/bi00213a035 · DOI
  139. Herberg, 1999, Dissection of the nucleotide and metal−phosphate binding sites in cAMP-dependent protein kinase, Biochemistry, 38, 6352, 10.1021/bi982672w · DOI · Paper page
  140. Herberg, 2000, Analysis of A-kinase anchoring protein (AKAP) interaction with protein kinase A (PKA) regulatory subunits: PKA isoform specificity in AKAP binding, J Mol Biol, 298, 329, 10.1006/jmbi.2000.3662 · DOI · Paper page
  141. Hida, 1998, Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas, Cancer Res, 58, 3761
  142. Hidaka, 1984, Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C, Biochemistry, 23, 5036, 10.1021/bi00316a032 · DOI · Paper page
  143. Hino, 2005, Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination, Mol Cell Biol, 25, 9063, 10.1128/MCB.25.20.9063-9072.2005 · DOI · Paper page
  144. Hiroi, 1998, Human ACTH hypersensitivity syndrome associated with abnormalities of the ACTH receptor gene, Clin Endocrinol (Oxf), 48, 129, 10.1046/j.1365-2265.1998.3971187.x · DOI
  145. Hollingsworth, 2004, Mucins in cancer: protection and control of the cell surface, Nat Rev Cancer, 4, 45, 10.1038/nrc1251 · DOI · Paper page
  146. Holz, 2008, Epac-selective cAMP analogs: new tools with which to evaluate the signal transduction properties of cAMP-regulated guanine nucleotide exchange factors, Cell Signal, 20, 10, 10.1016/j.cellsig.2007.07.009 · DOI
  147. Honeyman, 2014, Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma, Science, 343, 1010, 10.1126/science.1249484 · DOI · Paper page
  148. Horvath, 2010, Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update, Hum Mutat, 31, 369, 10.1002/humu.21178 · DOI · Paper page
  149. Horvath, 2008, Large deletions of the PRKAR1A gene in Carney complex, Clin Cancer Res, 14, 388, 10.1158/1078-0432.CCR-07-1155 · DOI
  150. Houslay, 2003, PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization, Biochem J, 370, 1, 10.1042/bj20021698 · DOI · Paper page
  151. Howe, 2004, Regulation of actin-based cell migration by cAMP/PKA, Biochim Biophys Acta, 1692, 159, 10.1016/j.bbamcr.2004.03.005 · DOI · Paper page
  152. Hsiao, 2009, Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors, J Clin Endocrinol Metab, 94, 2930, 10.1210/jc.2009-0516 · DOI · Paper page
  153. Hu, 2018, Disease-causing mutations in the G Protein Galphas subvert the roles of GDP and GTP, Cell, 173, 1254, 10.1016/j.cell.2018.03.018 · DOI
  154. Huang, 1999, NH2-Terminal targeting motifs direct dual specificity A-kinase-anchoring protein 1 (D-AKAP1) to either mitochondria or endoplasmic reticulum, J Cell Biol, 145, 951, 10.1083/jcb.145.5.951 · DOI · Paper page
  155. Huang, 2002, Protein kinase A deficiency causes axially localized neural tube defects in mice, J Biol Chem, 277, 19889, 10.1074/jbc.M111412200 · DOI
  156. Huh, 2014, Novel nonsense GNAS mutation in a 14-month-old boy with plate-like osteoma cutis and medulloblastoma, J Dermatol, 41, 319, 10.1111/1346-8138.12284 · DOI
  157. Iacovazzo, 2016, Gigantism: X-linked acrogigantism and GPR101 mutations, Growth Horm IGF Res, 30-31, 64, 10.1016/j.ghir.2016.09.007 · DOI
  158. Ideno, 2013, Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype, Ann Surg, 258, 141, 10.1097/SLA.0b013e31828cd008 · DOI
  159. Iglesias-Bartolome, 2015, Inactivation of a Gα(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis, Nat Cell Biol, 17, 793, 10.1038/ncb3164 · DOI
  160. Impey, 2004, Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions, Cell, 119, 1041
  161. Innamorati, 2018, The curious case of Gαs gain-of-function in neoplasia, BMC Cancer, 18, 293, 10.1186/s12885-018-4133-z · DOI
  162. Javaid, 2019, Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium, Orphanet J Rare Dis, 14, 139, 10.1186/s13023-019-1102-9 · DOI · Paper page
  163. Jeong, 2013, cAMP signalling decreases p300 protein levels by promoting its ubiquitin/proteasome dependent degradation via Epac and p38 MAPK in lung cancer cells, FEBS Lett, 587, 1373, 10.1016/j.febslet.2013.03.010 · doi:10.1016/j.febslet.2013.03.010
  164. Jho, 2018, Dual role of YAP: oncoprotein and tumor suppressor, J Thorac Dis, 10, S3895, 10.21037/jtd.2018.10.70 · DOI
  165. Johnson, 2001, Dynamics of cAMP-dependent protein kinase, Chem Rev, 101, 2243, 10.1021/cr000226k · DOI · Paper page
  166. Julius, 2012, Signaling by sensory receptors, Cold Spring Harb Perspect Biol, 4, a005991, 10.1101/cshperspect.a005991 · DOI
  167. Kaelin, 2005, The concept of synthetic lethality in the context of anticancer therapy, Nat Rev Cancer, 5, 689, 10.1038/nrc1691 · DOI · Paper page
  168. Kajiyama, 2014, Extremely poor postrecurrence oncological outcome for patients with recurrent mucinous ovarian cancer, Int J Clin Oncol, 19, 121, 10.1007/s10147-013-0522-0 · doi:10.1007/s10147-013-0522-0
  169. Kamilaris, 2019, Carney Complex, Exp Clin Endocrinol Diabetes, 127, 156, 10.1055/a-0753-4943 · DOI
  170. Kan, 2010, Diverse somatic mutation patterns and pathway alterations in human cancers, Nature, 466, 869, 10.1038/nature09208 · DOI · Paper page
  171. Kandel, 2012, The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB, Mol Brain, 5, 14, 10.1186/1756-6606-5-14 · DOI · Paper page
  172. Kaper, 1995, Cholera, Clin Microbiol Rev, 8, 48, 10.1128/CMR.8.1.48 · DOI · Paper page
  173. Kase, 1987, K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases, Biochem Biophys Res Commun, 142, 436, 10.1016/0006-291X(87)90293-2 · DOI · Paper page
  174. Kastenhuber, 2017, DNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma, Proc Natl Acad Sci USA, 114, 13076, 10.1073/pnas.1716483114 · DOI · Paper page
  175. Kaur, 2013, Mucins in pancreatic cancer and its microenvironment, Nat Rev Gastroenterol Hepatol, 10, 607, 10.1038/nrgastro.2013.120 · DOI · Paper page
  176. Kawamori, 2003, Enhancement of colon carcinogenesis by prostaglandin E2 administration, Carcinogenesis, 24, 985, 10.1093/carcin/bgg033 · DOI · Paper page
  177. Kee, 1996, Adaptor-mediated recruitment of RNA polymerase II to a signal-dependent activator, J Biol Chem, 271, 2373, 10.1074/jbc.271.5.2373 · DOI · Paper page
  178. Kemp, 1977, Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase, J Biol Chem, 252, 4888, 10.1016/S0021-9258(17)40137-2 · DOI · Paper page
  179. Kennedy, 2015, Selective disruption of the AKAP signaling complexes, Methods Mol Biol, 1294, 137, 10.1007/978-1-4939-2537-7_11 · DOI
  180. Khan, 2018, Induced GnasR201H expression from the endogenous Gnas locus causes fibrous dysplasia by up-regulating Wnt/β-catenin signaling, Proc Natl Acad Sci USA, 115, E418, 10.1073/pnas.1714313114 · DOI
  181. Kijima, 2016, Molecular classification of medulloblastoma, Neurol Med Chir (Tokyo), 56, 687, 10.2176/nmc.ra.2016-0016 · DOI
  182. Kim, 2007, PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation, Cell, 130, 1032, 10.1016/j.cell.2007.07.018 · DOI · Paper page
  183. Kim, 2006, Structure and dynamics of PKA signaling proteins, Eur J Cell Biol, 85, 651, 10.1016/j.ejcb.2006.02.004 · doi:10.1016/j.ejcb.2006.02.004
  184. Kim, 2015, J Biol Chem, 290, 9604, 10.1074/jbc.M114.633198 · DOI
  185. Kim, 2013, cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes, EMBO J, 32, 1543, 10.1038/emboj.2013.102 · DOI · Paper page
  186. Kim, 2019, FusionGDB: fusion gene annotation DataBase, Nucleic Acids Res, 47, D994, 10.1093/nar/gky1067 · DOI
  187. Kirschner, 2000, Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex, Hum Mol Genet, 9, 3037, 10.1093/hmg/9.20.3037 · DOI · Paper page
  188. Knape, 2017, Divalent metal ions control activity and inhibition of protein kinases, Metallomics, 9, 1576, 10.1039/C7MT00204A · DOI
  189. Knighton, 1991, Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase, Science, 253, 407, 10.1126/science.1862342 · DOI · Paper page
  190. Knighton, 1991, Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase, Science, 253, 414, 10.1126/science.1862343 · DOI · Paper page
  191. Kolligs, 2002, Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis, Digestion, 66, 131, 10.1159/000066755 · DOI · Paper page
  192. Komatsu, 2014, A GNAS mutation found in pancreatic intraductal papillary mucinous neoplasms induces drastic alterations of gene expression profiles with upregulation of mucin genes, PLoS One, 9, 10.1371/journal.pone.0087875 · DOI
  193. Kool, 2014, Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition, Cancer Cell, 25, 393, 10.1016/j.ccr.2014.02.004 · DOI · Paper page
  194. Lacka, 2015, Rare thyroid non-neoplastic diseases, Thyroid Res, 8, 5, 10.1186/s13044-015-0017-3 · DOI
  195. Landis, 1989, GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours, Nature, 340, 692, 10.1038/340692a0 · DOI · Paper page
  196. Langeberg, 2015, Signalling scaffolds and local organization of cellular behaviour, Nat Rev Mol Cell Biol, 16, 232, 10.1038/nrm3966 · DOI · Paper page
  197. Lania, 2006, Mechanisms of disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases, Nat Clin Pract Endoc, 2, 681, 10.1038/ncpendmet0324 · DOI
  198. Lanzi, 1992, Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas, Oncogene, 7, 2189
  199. Larkin, 2014, Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas, Eur J Endocrinol, 171, 705, 10.1530/EJE-14-0545 · DOI
  200. Lavogina, 2010, Bisubstrate inhibitors of protein kinases: from principle to practical applications, ChemMedChem, 5, 23, 10.1002/cmdc.200900252 · DOI

200 of 392 shown

Cited by

See all 82

Metadata

Authors
Ramms, D. J., Raimondi, F., Arang, N., Herberg, F. W., Taylor, S. S., & Gutkind, J. S.
Venue
Pharmacological Reviews
Publisher
Elsevier BV
Published
2021-10
Volume
73
Issue
4
Pages
1326-1368
ISSN
0031-6997
Cited by
82
References
35
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gαs–Protein Kinase A (PKA) Pathway Signalopathies: The Emerging Genetic Landscape and Therapeutic Potential of Human Diseases Driven by Aberrant Gαs-PKA Signaling. https://app.cochat.ai/papers/10.1124/pharmrev.120.000269
The paper
Ramms, D. J., Raimondi, F., Arang, N., Herberg, F. W., Taylor, S. S., & Gutkind, J. S. (2021). Gαs–Protein Kinase A (PKA) Pathway Signalopathies: The Emerging Genetic Landscape and Therapeutic Potential of Human Diseases Driven by Aberrant Gαs-PKA Signaling. Pharmacological Reviews. https://doi.org/10.1124/pharmrev.120.000269

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.